-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
-
Summary
-
Sagimet Biosciences Inc. annual and quarterly Net Cash Provided by (Used in) Operating Activities in USD history and change rate from 31 Mar 2022 to 31 Dec 2025.
- Sagimet Biosciences Inc. Net Cash Provided by (Used in) Operating Activities for the quarter ending 31 Mar 2025 was $14,536,000, a 134% decline year-over-year.
- Sagimet Biosciences Inc. annual Net Cash Provided by (Used in) Operating Activities for 2025 was $45,650,000, a 7.6% decline from 2024.
- Sagimet Biosciences Inc. annual Net Cash Provided by (Used in) Operating Activities for 2024 was $42,435,000, a 79% decline from 2023.
- Sagimet Biosciences Inc. annual Net Cash Provided by (Used in) Operating Activities for 2023 was $23,766,000, a 3% increase from 2022.